Fertility Preservation

Many advances in fertility preservation have been developed over the course of the last decade and many more are in the pipeline. Fertility preservation strategies have become increasingly available for both benign and malignant disease indications, as well as for non-medical indications, the latter highly related to the current trends in postponing childbearing and family building.

To offer guidance and to overcome challenges for reproductive medicine practitioners in fertility preservation area, we established Fertility Preservation SIG. We hope to provide a good platform for discussion, exchange, sustainable development for reproductive medicine clinician, embryologists, and oncologist.

Chairperson

Professor Rong Li
China
Email: roseli001@sina.com

Co-chairperson

Associate Professor Kate Stern
Australia
Email: kate.stern@mivf.com.au